Omnix O Tablet contains a combination of Cefixime 200 mg and Ofloxacin 200 mg, which are broad-spectrum antibiotics used to treat a variety of bacterial infections. Cefixime, a third-generation cephalosporin, acts by inhibiting bacterial cell wall synthesis, leading to cell death, whereas Ofloxacin, a fluoroquinolone, interferes with bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription. This synergistic combination enhances antibacterial efficacy against both Gram-positive and Gram-negative pathogens, making Omnix O suitable for treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted infections. The tablet should be administered orally as prescribed by a healthcare professional, typically with or without food, ensuring adherence to the full course to prevent resistance development. Caution is advised in patients with known hypersensitivity to cephalosporins or fluoroquinolones, and use should be avoided in individuals with a history of tendon disorders related to fluoroquinolones. Common side effects may include gastrointestinal disturbances, dizziness, and hypersensitivity reactions. Omnix O is contraindicated in pregnant or breastfeeding women unless deemed essential by a physician. Proper dosage adjustment is necessary in patients with renal impairment. Always consult a healthcare provider before initiating therapy with Omnix O Tablet.